Cradle

What

Cradle is an AI platform for protein engineering that helps R&D teams generate protein candidates, manage experimental rounds, and learn from wet lab results over time. It is aimed at biopharma and industrial biotechnology teams working on proteins such as antibodies, enzymes, vaccines, and peptides.

The workflow centers on importing experimental data or defining project goals, using AI to generate optimized protein sequences under selected constraints, reviewing predicted performance and mutations in reports, and then validating candidates in the lab or through a CRO. Based on the site content, Cradle is positioned as a software platform for accelerating hit identification, lead optimization, and broader protein development workflows rather than as a contract research lab.

Features

• AI-guided protein candidate generation: Generates lab-ready protein variants based on project goals, constraints, and existing experimental data to reduce manual sequence design effort.
• Learning from iterative wet lab data: Updates custom models as assay results are uploaded, which helps improve recommendations across successive optimization rounds.
• Multi-property optimization: Supports balancing properties such as activity, binding, stability, specificity, and expression so teams can address trade-offs in a single design cycle.
• Generation reports and sequence review: Provides predicted performance scores, plate-level views, and 3D mutation exploration to support candidate selection before lab testing.
• Round tracking and assay progress visibility: Lets teams monitor round status and view live metrics by protein property as experimental data comes in.
• Privacy and managed infrastructure: Keeps customer data private to the organization’s models, with SOC 2 compliance, SSO support, and fully managed AI infrastructure described on the page.

Helpful Tips

• Assess assay quality early: For products in this category, model performance depends heavily on experimental data quality, so early review of assay consistency and signal quality is important.
• Start with clear optimization targets: Multi-property design works best when teams define measurable priorities and constraints up front, including which trade-offs are acceptable.
• Plan for closed-loop execution: The value of an AI protein engineering platform increases when design, testing, and data upload happen in a disciplined recurring cycle.
• Review operational fit beyond model quality: Round tracking, reporting, data controls, and sequence handoff to internal labs or CROs can matter as much as raw generation capability.
• Validate security and IP handling for sensitive programs: For therapeutic and industrial bio projects, privacy terms, ownership terms, and access controls should be reviewed carefully during evaluation.

OpenClaw Skills

Cradle could likely fit well into the OpenClaw ecosystem as part of protein R&D orchestration workflows. Likely OpenClaw skills could include agents that collect assay outputs from lab systems, normalize experimental metadata, prepare structured uploads for model training, summarize generation reports, and route selected candidates into downstream procurement or CRO coordination workflows. The site does not state a native OpenClaw integration, so this should be treated as a likely implementation pattern rather than a confirmed capability.

In practice, this combination could support computational biology, antibody engineering, enzyme development, and translational research teams by turning Cradle into one step within a larger semi-automated decision system. Likely OpenClaw workflows might include portfolio-level experiment tracking, candidate review assistants, IP-aware documentation agents, and scientific reporting copilots that connect design rounds to project milestones. For protein engineering organizations, that could shift work from fragmented manual coordination toward more repeatable, data-driven development operations.